Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 4/20 | 1.00 |
| ▸ | PDE4A | P27815 | 2/20 | 1.00 |
| ▸ | SNCA | P37840 | 2/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | MAOB | P27338 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | ALOX5 | P09917 | 8/20 | 0.52 |
| ▸ | DHODH | Q02127 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Menaquinone 7 SCHEMBL15438185 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3AMAPT | |
| SCHEMBL10055449 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3AMAPT | |
| SCHEMBL14164356 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3AMAPT | |
| SCHEMBL8709976 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3AMAPT | |
| Menaquinone 7 SCHEMBL436068 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3AMAPT | |
| Menatetrenone SCHEMBL571912 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3AMAPT | |
| SCHEMBL10054546 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3AMAPT | |
| Menatetrenone SCHEMBL8703544 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3AMAPT | |
| SCHEMBL571907 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3AMAPT | |
| SCHEMBL14164358 | 1.00 | PTGS1 (1.00) | PTGS1PDE4ASNCAPDE3AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8570 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3727367-B1 | VITAMIN K2 COMPOSITIONS FOR USE IN THE TREATMENT OF DRUG INDUCED NEUROPATHY | SYNERGIA LIFE SCIENCES PVT LTD (IN) | 2026-05-27 | — | — | EP | claimed |
| CN-122075423-A | Selenium-containing compound vitamin chewable tablet and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122081263-A | Normenadione methyltransferase mutant and construction method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122038495-A | Preparation method for producing vitamin K2 by bacillus natto high-density fermentation | 石家庄燕科生物科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026087629-A1 | LIVE SACCHAROMYCES CEREVISIAE STRAINS FOR THE TREATMENT AND/OR PREVENTION OF BONE-LOSS DISORDERS | LESAFFRE ET COMPAGNIE (FR) | 2026-04-30 | — | — | WO | claimed |
| US-20260115151-A1 | VITAMIN AND MINERAL SHOT | BARRANCO CORINNE (US) | 2026-04-30 | — | — | US | claimed |
| EP-4732843-A1 | LIVE SACCHAROMYCES CEREVISIAE STRAINS FOR THE TREATMENT OF BONE-LOSS DISORDERS | Lesaffre et Compagnie (FR) | 2026-04-29 | — | — | EP | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| EP-4724104-A1 | SYNERGISTIC COMPOSITION FOR ENHANCING THE SOLUBILITY, STABILITY, BIOAVAILABILTY AND IMMEDIATE RELEASE OF ACTIVE COMPOUNDS | Olene Life Sciences Private Limited (IN) | 2026-04-15 | — | — | EP | claimed |
| EP-4719431-A1 | PREBIOTICS FOR TREATING AND/OR PREVENTING VITAMIN K2 DEFICIENCY | Société des Produits Nestlé S.A. (CH) | 2026-04-08 | — | — | EP | claimed |
| WO-2000004930-A2 | METHOD FOR INACTIVATION OF MICROORGANISMS USING PHOTOSENSITIZERS | GAMBRO, INC. (US) | 2000-02-03 | — | — | WO | claimed |
| WO-1999063982-A1 | WOUND TREATMENT THROUGH INHIBITION OF ADENOSINE DIPHOSPHATE RIBOSYL TRANSFERASE | UNIVERSITY OF MEDICINE & DENTISTRY OF NEW JERSEY (US) | 1999-12-16 | — | — | WO | claimed |
| EP-0759748-A1 | USES OF A VITAMIN OF THE K-GROUP AGAINST A LOSS OF COGNITIVE FACULTIES | Kohlmeier, Martin (US) | 1997-03-05 | — | — | EP | claimed |
| WO-1996024345-A2 | USES OF A VITAMIN OF THE K-GROUP AGAINST A LOSS OF COGNITIVE FACULTIES | KOHLMEIER MARTIN (US) | 1996-08-15 | — | — | WO | claimed |
| WO-1996019208-A1 | USE OF A VITAMIN OF THE K GROUP FOR TREATING HYPERPARATHYROIDISM | BARTZ, VOLKER (DE) | 1996-06-27 | — | — | WO | claimed |
| EP-0385335-B1 | Stabilized fat-soluble vitamin compositions | NISSHIN FLOUR MILLING CO (JP) | 1995-05-03 | — | — | EP | claimed |
| EP-0638309-A1 | Substances inhibiting proteic adp ribosilation suitable to prevent the diabetes mellitus complications | ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. (IT) | 1995-02-15 | — | — | EP | claimed |
| EP-0496349-A1 | Coating solution for preventing adhesion of polymer scale and method for its use | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1992-07-29 | — | — | EP | claimed |
| EP-0350864-B1 | AQUEOUS SOLUTION CONTAINING FAT-SOLUBLE VITAMIN K | Eisai Co., Ltd. (JP) | 1992-04-15 | — | — | EP | claimed |
| EP-0350864-A1 | Aqueous solution containing fat-soluble vitamin K | Eisai Co., Ltd. (JP) | 1990-01-17 | — | — | EP | claimed |